DrugPatentWatch Database Preview
Try a free trialSee Plans and Pricing
« Back to Dashboard
The generic ingredient in ANNOVERA is ethinyl estradiol; segesterone acetate. There are twenty-six drug master file entries for this compound. Additional details are available on the ethinyl estradiol; segesterone acetate profile page.
Generic Entry Opportunity Date for 209627
Generic Entry Date for 209627*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
|Approval Date:||Aug 10, 2018||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Aug 10, 2023|
|Regulatory Exclusivity Use:||NEW CHEMICAL ENTITY|
Complete Access Available with Subscription